ReviewFrontiers in nutrition2026
Dietary fiber, gut microbiota, and host immunity: the immunomodulatory roles of short-chain fatty acids.
Review in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Short-chain fatty acids (SCFAs) are a class of key metabolites produced by the gut microbiota through the fermentation of indigestible components such as dietary fiber. They primarily include acetate, propionate, and butyrate. In recent years, a large body of research has revealed that SCFAs are not only an important energy source for colonic epithelial cells but also key signaling molecules linking the gut microbiota to the host immune system. SCFAs play a central role in immune regulation. This review summarizes the production and characteristics of SCFAs. It explores the multifaceted roles of SCFAs in regulating immune homeostasis and inflammatory responses. Through key mechanisms such as activation of G protein-coupled receptors (GPCRs), inhibition of histone deacetylases (HDACs), and metabolic reprogramming, SCFAs broadly regulate the differentiation, function, and inflammatory responses of immune cells, maintain intestinal barrier integrity, and induce an anti-inflammatory state. At the same time, the manuscript analyzes the molecular mechanisms by which SCFAs contribute to inflammatory bowel disease, metabolic disorders, tumor immunity, and neuro-immune diseases through multi-organ pathways such as the "gut-liver axis" and the "gut-brain axis". In addition, this article summarizes treatment strategies targeting SCFAs, including dietary interventions, probiotics, prebiotics, and fecal microbiota transplantation. It also discusses the current challenges in this field and outlines future directions, with the aim of providing new insights for the prevention and treatment of immune-related diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.